PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using our proprietary NovaSperse nanoparticle technology and other complementary formulation and drug delivery technologies.

       Our platform nanoparticle technology provides amorphous nanoparticles of precisely controlled size, shape and distribution.

       We focus our internal programs on low-risk, fast-to-market products, to generate revenues via partnering and out-licensing worldwide.  We also offer the opportunity for the contractual preparation of nanoparticulate materials for pharmaceutical clients.

       Our pipeline includes medically needed high value global products in Women’s Health, and the adjacent areas of oncology, urology, and anti-infectives:

o   non-hormonal treatments for vasomotor instability e.g. hot flushes of the menopause and of the treatments for prostate and breast cancers.

o   nanoparticulate chemotherapeutics and anti-infectives

 

 

 

  

Recent News

Wednesday, September 11, 2013
PharmaNova Announces Reorganization
PharmaNova Announces Reorganization Victor, NY  September 11, 2013 --- PharmaNova Inc. announced the following changes effective August 1, 2013: Dr. Michael Violante has been appointe...

Monday, July 15, 2013
PharmaNova and Eternity Healthcare Sign Letter of Intent to Develop New Branded Pharmaceuticals
  PharmaNova and Eternity Healthcare Sign Letter of Intent to Develop New Branded Pharmaceuticals Victor, NY and Vancouver, BC July 15, 2013 --- PharmaNova Inc. announced today it has...

Monday, April 08, 2013
PharmaNova to Attend BIO International 2013 held at McCormick Place, Chicago, IL, April 22-24, 2013.
 PharmaNova to Attend BIO International 2013 held at McCormick Place, Chicago, IL, April 22-24, 2013.  PharmaNova will be attending the annual BIO International Convention 2013, A...

Wednesday, December 12, 2012
PharmaNova to Present at BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Square in San Francisco, CA held on January 7-9 2013.
PharmaNova Inc.will be presenting at the BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Square in San Francisco, CA held on January 7-9 2013. The presentation will held on Wednesda...

Thursday, May 17, 2012
PharmaNova to Present at the Biotechnology Symposium held at the Oncenter Complex, Syracuse NY, May 21-22 2012.
PharmaNova Inc. will be presenting at the Biotechnology Symposium held at the Oncenter Complex in Syracuse, NY  held on May 21-22 2012.   The presentation entitled  ...

Tuesday, May 08, 2012
PharmaNova’s U.S. Licensee and Partner, Depomed, Inc., Announces Intent to File NDA for Serada for Treatment of Menopausal Hot Flashes.
PharmaNova, Inc. of Victor, New York announced today that its US licensee and development partner, Depomed, Inc., (DEPO Nasdaq) intends to file a New Drug Application (NDA) wi...

Tuesday, March 01, 2011
PharmaNova Fuels Business Growth with Lacerta Bio Partnership
Victor, New York (March 1st., 2011):  PharmaNova, Inc. (PharmaNova) announces an agreement with Lacerta Bio, Inc. whereby Lacerta Bio’s experienced team of business developme...

Monday, January 24, 2011
PharmaNova to Present Poster at Controlled Release Product Development Forum on Poorly Soluble Drugs, January 27-28, 2011, Miami FL.
PharmaNova, Inc. of Victor, NY announced that Dr. Deepak Thassu, Chief Scientific Officer and VP Product Development at PharmaNova will be presenting a poster at the Controlled Release P...

Monday, November 08, 2010
PharmaNova, Inc. to Exhibit at the Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Sciences World Congress, New Orleans LA, Morial Convention Center, November 14-18, 2010.
PharmaNova will be exhibiting NovaSperse℠ nanoparticle technology capabilities at the Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Science...

Thursday, November 04, 2010
NovaSperse℠ Nanoparticle Innovator, PharmaNova, Inc. Awarded Four Government Grants toward Development of New Therapeutic Products under Congressional Qualifying Therapeutic Discovery Project Initiative.
NovaSperse℠ Nanoparticle Innovator, PharmaNova, Inc.  Awarded Four Government Grants toward Development of New Therapeutic Products under Congressional Qualifying Therapeutic Disc...

Thursday, August 12, 2010
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc. Starts Final Phase 3 Hot Flash Trial Enrollment after SPA Agreement with FDA.
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc. Starts Final Phase 3 Hot Flash Trial Enrollment after SPA Agreement with FDA.      P...

Monday, July 12, 2010
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc., Announces Anticipated September 2010 Enrollment for Final Phase 3 Clinical Trial.
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc., Announces Anticipated September 2010 Enrollment for Final Phase 3 Clinical Trial.   PharmaNova, I...

Wednesday, June 02, 2010
PharmaNova Invited to Speak at the Controlled Release Society (CRS) Soapbox Session Innovations Sunday Series in Portland, Oregon, July 11, 2010
June 2, 2010 PharmaNova Invited to Speak at the Controlled Release Society (CRS) Soapbox Session Innovations Sunday Series in Portland, Oregon, July 11, 2010 Dr. Deepak Thassu of PharmaNov...

Monday, May 03, 2010
PharmaNova to Exhibit at Annual Controlled Release Society (CRS) Meeting in Portland, Oregon July 10-14, 2010
PharmaNova to Exhibit at Annual Controlled Release Society (CRS) Meeting in Portland, Oregon July 10-14, 2010 PharmaNova Inc. will be exhibiting the latest advances of their proprietary Nov...

Monday, April 12, 2010
PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery” at New York Biotechnology Association (NYBA) Annual Meeting in New York City, Marriot Marquis, Times Square, April 19-20 2010.
PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery” at New York Biotechnology Association (NYBA) Annual Meeting in New York City, Marri...

Monday, March 15, 2010
PharmaNova, Inc. Announces Acceptance of Publication of Dr. Deepak Thassu’s Book, Ocular Drug Delivery System: Barriers and Application of Nanoparticulate Systems
PharmaNova, Inc. of Victor, NY announced today, March 15, 2010, Dr. Deepak Thassu’s book, Ocular Drug Delivery System: Barriers and Application of Nanoparticulate Systems  has bee...

Monday, February 08, 2010
PharmaNova to Present at Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Sciences World Congress, New Orleans LA, November 14-18, 2010
PharmaNova to Present at Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Sciences World Congress, New Orleans LA, November 14-18, 2010 PharmaNova ...

Thursday, February 04, 2010
PharmaNova’s U.S Development and Commercial Partner, Depomed Inc., Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes Under the FDA’s Special Protocol Assessment (SPA)
PharmaNova’s U.S Development and Commercial Partner, Depomed Inc., Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Meno...

Thursday, January 28, 2010
PharmaNova Featured in January 2010 Drug Delivery Technology Journal as Rising Drug Delivery Company
PharmaNova Inc of Victor, New York recognized in the January 2010 issue of Drug Delivery Technology as a company “On The Rise, Drug Delivery Companies You Should Know About”. P...

Tuesday, September 08, 2009
PharmaNova to exhibit at AAPS Annual Convention, Los Angeles, CA November 8-12, 2009
PharmaNova Inc. will be exhibiting at the AAPS Annual Convention to be held in the Los Angeles Convention Center November 8-12.  Exhibit details will be forthcoming.   The eve...

Tuesday, September 08, 2009
PharmaNova to present at Life Sciences Summit 2009, Long Island, NY September 23-24
Rodney A. Brown, President, PharmaNova Inc. will be a presenting delegate at the Life Sciences Summit at the Hyatt Regency Long Island, Hauppauge, NY on September 23 -24, 2009.    ...

Monday, April 06, 2009
PharmaNova, Inc.  and Altacor Ltd., form Strategic Alliance to develop new ophthalmic medicines.
PharmaNova Inc., (PharmaNova), of Rochester, New York, USA, and Altacor Ltd., (Altacor), of Cambridge, England, announced today that they have formed a strategic alliance to develop and comm...

Friday, November 14, 2008
Debut of PharmaNova’s NovaSpersesm at AAPS Annual Meeting in Atlanta
PharmaNova will be unveiling its new drug delivery technology NovaSpersesm at the AAPS meeting in Atlanta.  PharmaNova scientists have been perfecting the platform and have developed a ...

Tuesday, October 21, 2008
PharmaNova to exhibit at AAPS Annual Convention, Atlanta, GA.  – November 16-20, 2008.
PharmaNova Inc. will be exhibiting at the AAPS Annual Convention to be held in Atlanta’s Georgia World Congress Center November 16-20.  Our display will be housed in booth #765. ...

Thursday, September 18, 2008
PHARMANOVA’S LICENSEE INITIATES PHASE 3 CLINICAL PROGRAM FOR NON-HORMONAL MENOPAUSAL HOT FLASH TREATMENT
PharmaNova’s licensee, Depomed, Inc., announced today the initiation of the first of two pivotal Phase 3 clinical trials for Gabapentin-GR®, a proprietary formulation of gabapentin...

Thursday, September 11, 2008
PharmaNova to present at BioPartnering Europe 2008
PharmaNova, Inc. and our affiliate company PharmaNova Europa Ltd. will be presenting and exhibiting at the annual BioPartnering Europe (2008) conference to be held in London, October 12-14th...

Monday, June 09, 2008
PharmaNova to exhibit at Bio-2008: San Diego Convention Center – June 17-20, 2008.
PharmaNova Inc. will be exhibiting in the NY State Bio Pavilion at the 2008 Bio International Conference and Exhibition to be held at the San Diego Convention Center June 17-20. The NYS pavi...

Friday, January 25, 2008
Rochester, NY, January 25th. 2008: PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development.
Press release:  Rochester, NY, January 25th. 2008. PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development. PharmaNova Inc. announced today that it has h...

Friday, August 17, 2007
PharmaNova to present at UK conference, BioPartnering Europe 2007.
Rochester, New York: August 17, 2007.  PharmaNova Inc. announced today that the company will be presenting at the 15th anniversary meeting of BioPartnering Europe (http://ww...

Wednesday, August 15, 2007
Rochester, NY: PharmaNova partners with diagnostics and device company, Rochester Innovations
PharmaNova Inc. announced today that it has entered into a collaboration with Rochester Innovations Inc., a specialty diagnostics and devices company of Rochester, NY.    The co...

Thursday, March 29, 2007
PharmaNova expands into new lab. facilities to accelerate its nanoparticle R&D. See "Contact us" for new address.
...

Friday, March 16, 2007
PharmaNova forms Strategic Alliance with Taiwan based Orient Europharma
PharmaNova Inc., announced today that it has formed a strategic alliance and collaboration with Orient Europharma Company Ltd. (OEP) of Taiwan, R.O.C. In this 2-way relationship, it is ...

Monday, March 12, 2007
PHARMANOVA'S LICENSEE DEPOMED FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR GABAPENTIN GR FOR THE TREATMENT OF POSTMENOPAUSAL HOT FLASHES
MENLO PARK, Calif., Mar 12, 2007 (BUSINESS WIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Dru...